Bryan Yoon
2022 - Terns Pharmaceuticals
In 2022, Bryan Yoon earned a total compensation of $938.5K as Chief Operating Officer, General Counsel and Secretary at Terns Pharmaceuticals, a 36% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $262,740 |
|---|---|
| Option Awards | $225,640 |
| Salary | $437,900 |
| Other | $12,200 |
| Total | $938,480 |
Yoon received $437.9K in salary, accounting for 47% of the total pay in 2022.
Yoon also received $262.7K in non-equity incentive plan, $225.6K in option awards and $12.2K in other compensation.
Rankings
In 2022, Bryan Yoon's compensation ranked 3,175th out of 5,760 executives tracked by ExecPay. In other words, Yoon earned more than 44.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,175 out of 5,760 | 45th |
Division Manufacturing | 1,784 out of 3,136 | 43rd |
Major group Chemicals And Allied Products | 844 out of 1,422 | 41st |
Industry group Drugs | 788 out of 1,323 | 40th |
Industry Pharmaceutical Preparations | 574 out of 969 | 41st |
Source: SEC filing on April 28, 2023.
Yoon's colleagues
We found two more compensation records of executives who worked with Bryan Yoon at Terns Pharmaceuticals in 2022.
News
Terns Pharmaceuticals CEO Senthil Sundaram's 2022 pay falls 37% to $2M
April 28, 2023
Terns Pharmaceuticals CEO Senthil Sundaram's 2021 pay falls 77% to $3.1M
April 29, 2022
LogicBio Therapeutics CEO Frederic Chereau's 2020 pay jumps 193% to $1.9M
April 27, 2021
LogicBio Therapeutics Senior Vice President, Head of Clinical Development Kenneth Huttner receives $765K in 2019
April 29, 2020